跳至主要内容
临床试验/NCT00092703
NCT00092703已完成3 期

A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 50 mg t.i.d. in Patients With Osteoarthritis

Organon and Co0 个研究点目标入组 6,000 人开始时间: 2002年6月27日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
6,000
主要终点
Discontinuations due to clinical and laboratory gastrointestinal adverse experiences during a 1 year treatment period.

研究概览

简要总结

The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.

详细描述

The duration of treatment is 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief

排除标准

  • Known allergies to the study drugs

结局指标

主要结局

Discontinuations due to clinical and laboratory gastrointestinal adverse experiences during a 1 year treatment period.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验